{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:13:15Z","timestamp":1793682795694,"version":"4.5.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11857-8","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:30:33Z","timestamp":1761744633000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of echinocandins combined with Trimethoprim-Sulfamethoxazole as first-line treatment for Pneumocystis pneumonia in HIV-infected and non-HIV-infected patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AiPing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"3","key":"11857_CR1","doi-asserted-by":"publisher","first-page":"e0036124","DOI":"10.1128\/jcm.00361-24","volume":"63","author":"OE Asowata","year":"2025","unstructured":"Alexis Jaramillo Cartagena, Asowata OE, Ng D, et al. An overview of the laboratory diagnosis of Pneumocystis jirovecii pneumonia. J Clin Microbiol. 2025;63(3):e0036124.","journal-title":"J Clin Microbiol"},{"key":"11857_CR2","unstructured":"Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available online: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections\/whats-new?guideline%5B0%5D=title_bookpart%3AHIV+Clinical+Guidelines%3A+Adult+and+Adolescent+Opportunistic+Infections&redirected=1 (accessed on 27 May 2025)."},{"issue":"9","key":"11857_CR3","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/jac\/dkw156","volume":"71","author":"A Alanio","year":"2016","unstructured":"Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with hematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2386\u201396.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"11857_CR4","first-page":"1017","volume":"17","author":"MC Koh","year":"2024","unstructured":"Koh MC, Ngiam JHN, Tambyah PA, et al. Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying HIV infection. J Infect Public Health. 2024;17(6):1017\u201324.","journal-title":"J Infect Public Health"},{"key":"11857_CR5","doi-asserted-by":"crossref","unstructured":"Nasr M, Mohammad A, Hor M et al. Exploring the Differences in Pneumocystis Pneumonia Infection Between HIV and Non-HIV Patients. Cureus.2022;14(8):e27727.","DOI":"10.7759\/cureus.27727"},{"issue":"8","key":"11857_CR6","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/j.transproceed.2017.04.020","volume":"49","author":"YM Lu","year":"2017","unstructured":"Lu YM, Lee YT, Chang HC, et al. Combination of echinocandins and trimethoprim\/sulfamethoxazole for the treatment of pneumocystis jiroveci pneumonia after heart transplantation. Transplant Proc. 2017;49(8):1893\u20138.","journal-title":"Transplant Proc"},{"key":"11857_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijid.2019.08.015","volume":"88","author":"F Jin","year":"2019","unstructured":"Jin F, Liu X-H, Chen W-C, et al. High initial (1, 3) Beta-d-glucan concentration may be a predictor of satisfactory response of Caspofungin combined with TMP\/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia. Int J Infect Dis. 2019;88:141\u20138.","journal-title":"Int J Infect Dis"},{"key":"11857_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8105075","volume":"2019","author":"M Wang","year":"2019","unstructured":"Wang M, Lang G, Chen Y, et al. A pilot study of Echinocandin combination with trimethoprim\/sulfamethoxazole and clindamycin for the treatment of AIDS patients with Pneumocystis pneumonia. J Immunol Res. 2019;2019:8105075.","journal-title":"J Immunol Res"},{"issue":"4","key":"11857_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/hiv.13013","volume":"22","author":"Q Tian","year":"2021","unstructured":"Tian Q, Si J, Jiang F, et al. Caspofungin combined with TMP\/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection. HIV Med. 2021;22(4):307\u201313.","journal-title":"HIV Med"},{"issue":"1","key":"11857_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08372-z","volume":"23","author":"H Qi","year":"2023","unstructured":"Qi H, Dong D, Liu N, et al. Efficacy of initial caspofungin plus trimethoprim\/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection. BMC Infect Dis. 2023;23(1):409.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11857_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12879-024-09031-7","volume":"24","author":"H Li","year":"2024","unstructured":"Li H, Lu Y. A regimen based on the combination of trimethoprim\/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related Pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital. BMC Infect Dis. 2024;24(1):152.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"11857_CR12","doi-asserted-by":"publisher","first-page":"102489","DOI":"10.1016\/j.jiac.2024.08.004","volume":"31","author":"S Jumpei Taniguchi","year":"2025","unstructured":"Jumpei Taniguchi S, Aso H, Matsui, et al. Trimethoprim-sulfamethoxazole combined with echinocandins versus trimethoprim-sulfamethoxazole alone for Pneumocystis pneumonia in patients without human immunodeficiency virus infection: A nationwide retrospective cohort study. J Infect Chemotherapy: Official J Japan Soc Chemother. 2025;31(1):102489.","journal-title":"J Infect Chemotherapy: Official J Japan Soc Chemother"},{"key":"11857_CR13","doi-asserted-by":"crossref","unstructured":"Hideo Kato M, Hagihara N, Asai et al. Efficacy of Trimethoprim-Sulfamethoxazole in Combination with an Echinocandin as a First-Line Treatment Option for Pneumocystis Pneumonia: A Systematic Review and Meta-Analysis. Antibiotics (Basel, Switzerland).2022;11(6):719.","DOI":"10.3390\/antibiotics11060719"},{"issue":"3","key":"11857_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/1120009X.2022.2095155","volume":"35","author":"J Guo","year":"2023","unstructured":"Guo J, Chen Z, Kong C, et al. Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia. J Chemother. 2023;35(3):181\u20137.","journal-title":"J Chemother"},{"issue":"9","key":"11857_CR15","first-page":"790","volume":"74","author":"MJ Page","year":"2021","unstructured":"Page MJ, Mckenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (online). 2021;74(9):790\u20139.","journal-title":"BMJ (online)"},{"issue":"9","key":"11857_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603\u20135.","journal-title":"Eur J Epidemiol"},{"key":"11857_CR17","unstructured":"The Newcastle-Ottawa. Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.pdf. (Access 21 Mar 2025)."},{"issue":"4","key":"11857_CR18","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"key":"11857_CR19","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"issue":"5","key":"11857_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176881","volume":"12","author":"A Ricciardi","year":"2017","unstructured":"Ricciardi A, Gentilotti E, Coppola L, et al. Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: a retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients. PLoS ONE. 2017;12(5):e0176881.","journal-title":"PLoS ONE"},{"issue":"1","key":"11857_CR21","first-page":"52","volume":"96","author":"JF Helmut","year":"2018","unstructured":"Helmut JF, Salzer G, Sch\u00e4fer M, Hoenigl, et al. Clinical, Diagnostic, and treatment disparities between HIV-Infected and Non-HIV-Infected immunocompromised patients with Pneumocystis jirovecii Pneumonia.Respiration. Int Rev Thorac Dis. 2018;96(1):52\u201365.","journal-title":"Int Rev Thorac Dis"},{"key":"11857_CR22","unstructured":"Reem S, Almaghrabi S, Alfuraih R, Alohaly, et al. Pneumocystis Jiroveci pneumonia in HIV-Positive and HIV-Negative patients: A Single-Center retrospective study. Volume 18. Tanaffos; 2019. pp. 238\u201343. 3."},{"key":"11857_CR23","doi-asserted-by":"crossref","unstructured":"Sorabh Datta S, Mahal et al. Virendrasinh,Ravat,. Hospitalization Outcomes in Pneumocystis Pneumonia Inpatient Population: A Comparison between HIV and Non-HIV Patients. Cureus.2018,10(8):e3082.","DOI":"10.7759\/cureus.3082"},{"issue":"1","key":"11857_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","volume":"135","author":"EL Murphy","year":"2001","unstructured":"Murphy EL, Collier AC, Kalish LA, et al. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease. Ann Intern Med. 2001;135(1):17\u201326.","journal-title":"Ann Intern Med"},{"key":"11857_CR25","doi-asserted-by":"crossref","unstructured":"Emily G, McDonald A, Afshar B, Assiri et al. Pneumocystis jirovecii pneumonia in people living with HIV: a review. Clin Microbiol Rev. 2024;37(1):e0010122\u20130010122.","DOI":"10.1128\/cmr.00101-22"},{"issue":"12","key":"11857_CR26","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/jphp.12780","volume":"69","author":"A Patil","year":"2017","unstructured":"Patil A, Majumdar S. Echinocandins in antifungal pharmacotherapy. J Pharm Pharmacol. 2017;69(12):1635\u201360.","journal-title":"J Pharm Pharmacol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11857-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11857-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:30:42Z","timestamp":1761744642000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11857-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11857"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11857-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1443"}}